window.pageData = {"stock":{"_id":3000000024982,"stockCode":"024982","masterFundShortName":"国泰创业板医药卫生ETF发起联接","fundSecondLevel":"company","stockType":"fund","areaCode":"cn","market":"a","tickerId":24982,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"国泰创业板医药卫生ETF发起联接A","name":"国泰创业板医药卫生交易型开放式指数证券投资基金发起式联接基金","pinyin":"gtcybyywsjyxkfszszqtzjjfqsljjj","fundCollectionId":4000050010000,"inceptionDate":"2025-09-25T16:00:00.000Z","setUpAssetScale":16178991.03,"setUpDate":"2025-09-25T16:00:00.000Z","setUpShares":16178991.03,"followedNum":0,"etfFundFlag":1,"feederFundFlag":1,"indexFundFlag":1,"fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"50010000","tickerId":50010000,"name":"国泰基金管理有限公司"},"managers":[{"name":"刘昉元","stockType":"fund_manager","stockCode":"j101020238","exchange":"fm","tickerId":120625253700}],"targetFunds":[{"shortName":"国泰创业板医药卫生ETF(159377)","stockType":"fund","stockCode":"159377","exchange":"sz","tickerId":159377}],"hotMetrics":{"fss":{"stockId":3000000024982,"type":"fss","last_data_date":"2025-12-30T16:00:00.000Z","f_ins_h_s_r":0.5609000000000001,"f_ind_h_s_r":0.4391,"f_h_a":927},"fpr":{"stockId":3000000024982,"type":"fpr","f_cagr_p_r_fs_ssc":5914,"f_cagr_p_r_fs_ssrp":0.989345509893455,"f_p_r_m1_ssc":5828,"f_p_r_m1_ssrp":0.9128196327441221,"f_p_r_m3_ssc":5700,"f_p_r_m3_ssrp":0.8994560449201614,"f_p_r_fys_ssc":5565,"f_p_r_fys_ssrp":0.9347591660675773,"f_p_r_m6_ssc":5414,"f_p_r_m6_ssrp":0.950489562165158},"fp":{"stockId":3000000024982,"type":"fp","last_data_date":"2026-05-21T16:00:00.000Z","f_cagr_p_r_fs":-0.18630000000000002,"f_p_r_m1":-0.06578645235361646,"f_p_r_m3":-0.10993218114198189,"f_p_r_fys":-0.10562761046383817,"f_p_r_m6":-0.11727055760468641},"ff":{"stockId":3000000024982,"type":"ff","f_fr_d":"2025-12-30T16:00:00.000Z","f_m_fr":0.005,"f_c_fr":0.001,"f_mac_fr":0.006},"f_nlacan":{"stockId":3000000024982,"type":"f_nlacan","f_nv_d":"2026-05-21T16:00:00.000Z","f_nv":0.8137,"f_nv_cr":-0.011300121506682803},"f_as":{"stockId":3000000024982,"type":"f_as","f_tas":13677503.764800001,"f_tas_d":"2026-03-30T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000024983,"name":"国泰创业板医药卫生交易型开放式指数证券投资基金发起式联接基金","fundSecondLevel":"company","stockType":"fund","areaCode":"cn","market":"a","status":"normal","indexFundFlag":1,"etfFundFlag":1,"feederFundFlag":1,"stockCode":"024983","tickerId":24983,"shortName":"国泰创业板医药卫生ETF发起联接C","currency":"CNY","__csrcFundId":15730,"exchange":"jj","masterFundFlag":null,"activeFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"classificationFlag":null,"closedEnd":null,"lastUpdated":"2025-10-10T22:43:00.451Z","inceptionDate":"2025-09-25T16:00:00.000Z","fundCollectionId":4000050010000,"pinyin":"gtcybyywsjyxkfszszqtzjjfqsljjj"}],"lastFsMetrics":{"latestTurnoverRate":0.6226213940299697,"latestTurnoverRateDate":"2025-12-30T16:00:00.000Z"}},"list":[{"_id":"69e8ecac1398d79843fea0b2","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","stockId":3000000024982,"sao":"一季度板块整体持续调整，消费医疗、医疗器械等方向仍处在弱复苏阶段，市场预期不高；另一方面，创新药自2025年四季度以来持续调整，市场担忧今年BD降速，以及没有重磅大BD等问题，因此板块表现弱于大盘。作为跟踪标的指数的被动型基金的联接基金，国泰创业板医药卫生ETF联接基金的主要持仓为创业板医药ETF国泰，本基金根据申赎情况进行调仓，保持90%以上仓位，以更好的跟踪创业板医药卫生指数的表现。","lastUpdated":"2026-04-22T15:43:40.644Z","fund":{"_id":3000000024982,"__csrcFundId":15730,"stockCode":"024982","masterFundShortName":"国泰创业板医药卫生ETF发起联接","fundSecondLevel":"company","stockType":"fund","areaCode":"cn","market":"a","tickerId":24982,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"国泰创业板医药卫生ETF发起联接(024982)","lastUpdated":"2026-05-01T04:30:44.491Z","name":"国泰创业板医药卫生交易型开放式指数证券投资基金发起式联接基金","pinyin":"gtcybyywsjyxkfszszqtzjjfqsljjj","fundCollectionId":4000050010000,"inceptionDate":"2025-09-25T16:00:00.000Z","setUpAssetScale":16178991.03,"setUpDate":"2025-09-25T16:00:00.000Z","setUpShares":16178991.03,"followedNum":0,"etfFundFlag":1,"feederFundFlag":1,"indexFundFlag":1,"managers":[{"stockCode":"j101020238","stockType":"fund_manager","exchange":"fm","tickerId":120625253700,"name":"刘昉元"}]},"announcement":{"linkText":"国泰创业板医药卫生交易型开放式指数证券投资基金发起式联接基金2026年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1475730","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69ca14290daeb17084fb2b37","date":"2025-12-30T16:00:00.000Z","declarationDate":"2026-03-29T16:00:00.000Z","stockId":3000000024982,"sao":"本基金2025年9月底成立，三季度创新药板块波动加大，总体来看 BD 数量和金额相比上半年有所放缓，部分公司对外授权金额或进度不及预期。相比之下，医疗设备和器械板块呈现复苏态势。四季度医药板块跑输市场，部分创新药企出海BD金额不及市场预期，此外消费医疗需求景气度依然较低，相关个股持续调整，板块整体延续下跌走势。作为跟踪标的指数的被动型基金的联接基金，创业板医药卫生ETF联接基金的主要持仓为创业板医药卫生ETF，本基金根据申赎情况进行调仓，保持90%以上仓位，以更好的跟踪创业板医药卫生指数的表现。","lastUpdated":"2026-03-30T06:11:53.111Z","mo":"在经历2025年四季度调整后，2026年继续看好医药板块性的机会，本轮创新药行情的核心驱动因素是中国药企在全球竞争力的突破，中国药企厚积薄发，产业趋势已经形成，研发实力逐步得到全球 MNC 认可，创新药 BD 出海及临床数据有望持续落地。此外以 AI、脑机接口等为代表的新兴产业有望逐步变革医药细分领域，带动产业链投资机会。","fund":{"_id":3000000024982,"__csrcFundId":15730,"stockCode":"024982","masterFundShortName":"国泰创业板医药卫生ETF发起联接","fundSecondLevel":"company","stockType":"fund","areaCode":"cn","market":"a","tickerId":24982,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"国泰创业板医药卫生ETF发起联接(024982)","lastUpdated":"2026-05-01T04:30:44.491Z","name":"国泰创业板医药卫生交易型开放式指数证券投资基金发起式联接基金","pinyin":"gtcybyywsjyxkfszszqtzjjfqsljjj","fundCollectionId":4000050010000,"inceptionDate":"2025-09-25T16:00:00.000Z","setUpAssetScale":16178991.03,"setUpDate":"2025-09-25T16:00:00.000Z","setUpShares":16178991.03,"followedNum":0,"etfFundFlag":1,"feederFundFlag":1,"indexFundFlag":1,"managers":[{"stockCode":"j101020238","stockType":"fund_manager","exchange":"fm","tickerId":120625253700,"name":"刘昉元"}]},"announcement":{"linkText":"国泰创业板医药卫生交易型开放式指数证券投资基金发起式联接基金2025年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1450338","linkType":"PDF","source":"csrc_pdf"}}]}